Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza - Test2 - elhamkhani - TriplyDB

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza

http://www.wikidata.org/entity/Q24652088

about

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists Induction of innate immunity and its perturbation by influenza viruses Influenza virus hemagglutinin stalk-based antibodies and vaccines Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach Vaccines: the Fourth Century Reverse Genetics Approaches for the Development of Influenza Vaccines Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development Changing risk awareness and personal protection measures for low to high pathogenic avian influenza in live-poultry markets in Taiwan, 2007 to 2012 A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Current and emerging cell culture manufacturing technologies for influenza vaccines.A paradigm shift in vaccine production for pandemic influenza.Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.H7N9 influenza virus neutralizing antibodies that possess few somatic mutations Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984.NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.Programming the magnitude and persistence of antibody responses with innate immunity.A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.New technologies for influenza vaccines.Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice.Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.H5N1 pathogenesis studies in mammalian models.Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines.Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly.Innate immune evasion strategies of influenza viruses The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets.A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses.The C-Terminal Effector Domain of Non-Structural Protein 1 of Influenza A Virus Blocks IFN-β Production by Targeting TNF Receptor-Associated Factor 3 Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

P2860

Q24614628-D0D31A51-18C6-406A-A2D8-F15A183199ED Q26745547-F4D844AE-860A-4C9F-9D1E-0F0D08F90C43 Q26800014-DC084F8F-F6C8-4B8D-B847-731B385B6214 Q27001190-577B6913-424D-4733-9FF5-A5769679461A Q27316846-B7BB909B-6FBD-435D-BA54-A16682708191 Q27490454-7AC6F935-34F8-4EB5-A05D-CDE88AE6A092 Q28076140-AC87B57E-637D-4115-B064-74A2AB65CA67 Q28395006-F6FAB101-D94C-4629-AF6D-C73E16D85546 Q28397058-340ADC7B-AAAE-4AAF-BE26-B7CB50C9982D Q28483298-402EAC25-0C1F-41B2-A86F-747AFF018D04 Q30227194-FBE334B0-C97B-42CB-A693-E650C3B9C0E1 Q30357094-3EA10B2A-5459-45F2-A082-6D5926A2F6DC Q30366669-1CD49AED-583F-4110-8A00-A9A46D7E06B7 Q30370147-1C0F1A43-D85C-4E1B-B79C-E520007CC90F Q30373128-3906D7A2-5F81-44E2-8538-AA1AC2571FFE Q30377766-61972536-C58A-4D7C-B7A6-0F02CAB96C83 Q30378132-6628AFA5-E386-481D-9128-8274DCAA5BFB Q30382576-62ED09AB-D487-48D3-AD16-FEA03ED9BED5 Q30385271-DE541818-6E42-4BC7-827B-9FC86C109E01 Q30385356-A7FA52FA-3C9C-422F-B22B-160A959F50B7 Q30385956-7F5AD2E5-ED16-49A4-A158-675B73AF73F4 Q30394706-151D3BA5-4A56-45EA-AD01-807992C0C147 Q30395264-D960FAFC-25C6-4497-B248-EDEBA37B4B60 Q30400144-3CD7C0C5-2A28-44B2-957D-D67B95DC5085 Q30402334-AC0193F9-6D78-4337-AFED-E14C6FEADA1E Q30406151-9D3F8338-BF3A-4A1E-8768-7D32AD92F03D Q30407424-8B2229C1-785F-4EB5-A15C-2138211C01EB Q30411859-54339064-3B67-4144-A941-795902D7AE1F Q30419085-AE285982-A77B-4CD7-B080-4919C70291D5 Q30423481-A7C8E94E-77D2-43F9-B006-ECF269C30ECC Q30427806-19C7ED02-276F-460E-A348-703BBF296FD8 Q30474419-58E07529-4410-4AD5-AB38-4F579D699765 Q30540603-A7AB6D3E-D3F5-42A0-86DD-6D8944C35091 Q33490614-0BB840E4-B926-4BAE-A449-3A56B98D46CC Q33622358-228404B7-9135-4C7C-9CF4-B4E38A2D25AE Q33646273-2B7E89DA-DB50-49FA-A8D2-DF0EFF769115 Q33700611-8A41C0C4-A8CD-4093-A5C4-3524D16F2EA1 Q33815195-FAF6689E-DA4F-4539-845A-44C0F3D1E0AF Q33863827-FCD73AF1-1979-4579-A005-3303AFCF539E Q33883224-A4AE3CD2-42F2-4227-94C7-1AD32595B88F

P2860

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza

http://www.wikidata.org/entity/Q24652088

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Live attenuated influenza viru ...... hly pathogenic avian influenza

@ast

Live attenuated influenza viru ...... hly pathogenic avian influenza

@en

Live attenuated influenza viru ...... hly pathogenic avian influenza

@nl

type

label

Live attenuated influenza viru ...... hly pathogenic avian influenza

@ast

Live attenuated influenza viru ...... hly pathogenic avian influenza

@en

Live attenuated influenza viru ...... hly pathogenic avian influenza

@nl

prefLabel

Live attenuated influenza viru ...... hly pathogenic avian influenza

@ast

Live attenuated influenza viru ...... hly pathogenic avian influenza

@en

Live attenuated influenza viru ...... hly pathogenic avian influenza

@nl

P1433

Q24652088-62F3EAC0-1181-4BE2-BEAF-3C4F89014330

P1476

Q24652088-AF906B30-6F83-404C-96A4-463335C14B66

P2093

Q24652088-47986663-CCBA-43F3-906E-696864782275

Q24652088-4D993D3E-DFE7-4282-90D8-CEF9613ECDFB

Q24652088-7FBD4297-200A-48E6-9753-844D782AE7E3

Q24652088-BE01FEDF-1D68-471F-92DE-4C5980000995

P2860

Q24652088-0916892C-F2DF-4100-82B0-9B21693443E0

Q24652088-0A873471-F746-421E-9977-DF43965B24DA

Q24652088-1881B519-3CF7-4D9D-A648-7B4009699A5A

Q24652088-28688D04-B3B9-443C-9DC1-FC92F7601A42

Q24652088-2BA3E320-FE4F-4DBA-B547-443BC5770C90

Q24652088-32DFC983-1790-433E-A784-9542AF64C301

Q24652088-416920A0-C0D9-4647-A5DD-CBB7CFDDB0EF

Q24652088-48658A16-F08D-4BC6-8C8F-DBC7642767A2

Q24652088-560382B3-CBDC-4325-9186-B0C0053F2F9C

Q24652088-588BC0B9-6174-41CC-8D20-0FDAF54F704A

P304

Q24652088-DCE63569-4E72-48CA-BEEA-9D28CAD78D64

P31

Q24652088-342B6424-79A9-4A69-A628-48164865FCA8

P356

Q24652088-D1899193-C03C-4DC7-9736-6B9A88D13B0E

P407

Q24652088-3E9653D9-D128-4FCE-87E2-AB75F210F46E

P433

Q24652088-228F8E2E-85C3-4A1A-B731-BF1930965EB4

P478

Q24652088-721158B6-0426-4B0B-B199-F84385065D46

P50

Q24652088-1DF28A00-741A-41EE-8984-55C6D0F6FC44

Q24652088-2FAE4DD4-010B-4387-9B05-D7FA5ECF4B95

Q24652088-402231AF-B04D-4C93-89DB-0A08D100DF8C

Q24652088-53F6C602-E130-4919-B2FA-49F97DB138EF

Q24652088-D85D269B-DD24-4C7F-814C-D3BE82FD7A63

P577

Q24652088-720B6F84-97DC-4C5C-B37F-91FB1AFE3C08

P698

Q24652088-E2786967-E711-4CFE-88F7-255CC293E8B9

P921

Q24652088-2B26B6D3-0320-4198-9D33-7DC48D5186C3

Q24652088-C3458F83-8FD7-462C-8AEC-B35787F205E2

P932

Q24652088-A073857C-1FB9-42FF-A629-A841583139DE

P356

P1433

Journal of Virology

P1476

Live attenuated influenza viru ...... hly pathogenic avian influenza

@en

P2093

Anice C Lowen

http://www.w3.org/2001/XMLSchema#string

John Steel

http://www.w3.org/2001/XMLSchema#string

Lindomar Pena

http://www.w3.org/2001/XMLSchema#string

Matthew Angel

http://www.w3.org/2001/XMLSchema#string

P2860

Pandemic Threat Posed by Avian Influenza A Viruses

Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus

An improved reverse genetics system for influenza A virus generation and its implications for vaccine production

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.

Update on avian influenza A (H5N1) virus infection in humans

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam.

P304

1742-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01920-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Daniel R. Perez

Adolfo García-Sastre

Randy A. Albrecht

Alicia Solórzano

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19073731

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

2643794

http://www.w3.org/2001/XMLSchema#string